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Rotavirus Vaccine Workshop Held
More than 125 participants from at least 15
countries attended the Fifth Rotavirus Vaccine
Workshop at the Centers for Disease Control and
Prevention (CDC) in Atlanta, Georgia, October
16-17, 1995.
Rotavirus has emerged as the most important
cause of severe diarrhea in children worldwide. It
is a problem not only in developing countries,
where it kills an estimated 870,000 children each
year, but also in the United States, where it re-
mains the most important single cause of hospi-
talization or clinic visits for childhood diarrhea.
Moreover, although studies from many coun-
tries indicate that only four serotypes are pre-
dominant worldwide, some strains at every site
studied cannot be serotyped. In some countries
such as India, the diversity of strains is extensive.
Further studies are needed to define the extent of
cross-protection against these strains that is in-
duced by the vaccine to determine whether addi-
tional antigens need to be included in vaccines for
such areas.
This workshop included sessions on epidemiol-
ogy, virology, pathogenesis and immunity, and vac-
cines currently being tested. Each session had
numerous presentations by leaders in the field of
rotavirus research. Researchers reported that sev-
eral live oral rotavirus vaccines, based on animal
strains of rotavirus combined with reassortant
strains, have been tested in field trials in children.
These appear to protect American children against
rotavirus and are more efficacious against severe
disease. These vaccines like natural protection,
are not 100% protective so many investigators are
exploring alternative approaches to vaccines such
as the use of virus-like particles, native DNA, and
microencapsulation of antigens.
No published volume of proceedings from the
workshop is planned, but a supplemental issue of
the Journal of Infectious Diseases scheduled for
early 1996 will contain papers from the meeting.
The workshop was held under the auspices of
the National Institutes of Health, Emory Univer-
sity School of Medicine, and the World Health
Organization.
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International Conference Addresses
Preparedness for Emerging Strains
of Pandemic Influenza
An international meeting on pertinent issues
related to recognizing, identifying, and controlling
newly emerging strains of pandemic influenza
was held in Bethesda, Maryland, December 11–
13, 1995. The conference, “Pandemic Influenza:
Confronting a Reemergent Threat,” was spon-
sored by the National Institutes of Health, the
University of Michigan, the Centers for Disease
Control and Prevention, the Food and Drug Ad-
ministration, the U.S.-Japan Cooperative Medical
Science Program, and the World Health
Organization.
Epidemic strains of influenza cause infections
almost every year throughout the world because
of continuous minor genetic changes in the virus.
However, periodically a major change occurs, such
as reassortment between mammalian and avian
strains of the virus. These pandemic strains are
novel to the human immune system and, there-
fore, can cause substantial disease worldwide. The
conference concentrated on issues that would be
crucial to controlling an influenza pandemic.
Plenary and workshop sessions examined the
following topics: Can pandemics be predicted?
What are the specific approaches for pandemic
control? What are the advantages and limitations
of vaccines and antiviral agents? The workshops
also focused on factors contributing to the emer-
gence of pandemic strains and various aspects of
surveillance, such as the adequacy of current
global surveillance structure for early identifica-
tion of a pandemic strain, the use of virologic and
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